Analysis on the Effect of Yiqi Huoxue Decoction Combined with Neuromuscular Electrical Stimulation in Improving ICU-Acquired Debility in Mechanically Ventilated Patients

To investigate the effect of Yiqi Huoxue decoction combined with neuromuscular electrical stimulation on improving intensive care unit (ICU) acquired debility in mechanically ventilated patients. Methods: 50 patients who were admitted to the ICU and received mechanical ventilation treatment in our hospital from June 2022 to June 2023 and were complicated with ICU-acquired neurasthenia were selected, and randomly grouped using the randomized envelope method into two groups: a control group with 25 patients who received neuromuscular electrical stimulation alone; observation group with 25 patients who received the traditional Chinese medicine Yiqi Huoxue decoction. Comparison indexes: treatment efficiency, degree of emotional recovery (APACHE Ⅱ score), muscle strength status (MRC score), motor status (FAC rating), and self-care ability (BI index score). Results: The treatment efficiency of patients in the observation group patients was higher as compared to those in the control group (P 0.05). After the treatment, the APACHE Ⅱ scores of patients in the observation group were significantly lower as compared to those in the control group, while the MRC scores, FAC ratings, and BI index scores were higher in the observation group than those of the control group patients (P < 0.05). Conclusion: The combined application of Yiqi Huoxue decoction and neuromuscular electrical stimulation in the treatment of patients with ICU-acquired neurasthenia complicated by mechanical ventilation significantly enhanced the clinical efficacy, the patient’s muscle strength, motor status, and ability of self-care. Hence, it has high application value and is worthy to be popularized.